Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

By: via Benzinga
On July 30, Pfizer (NYSE: PFE) announced that it had entered into a definitive agreement to acquire Baxter International's (NYSE: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.